IDXX analyst estimates
Idexx Laboratories (IDXX) analyst ratings, the average price target and its range, and every firm's latest call.
- 8 firms rate IDXX: 5 buy, 3 hold, 0 sell.
- The average price target is $725.00 from None analysts, from $700.00 to $750.00.
IDXX analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Nov 3, 2026 | UBS | IDEXX Laboratories (IDXX) PT Raised to $700 at UBS | $700.00 |
| Oct 27, 2026 | UBS | Idexx Laboratories price target lowered to $627 from $670 at UBS | $627.00 |
| Oct 16, 2026 | Goldman Sachs | Idexx Laboratories initiated with a Buy at Goldman Sachs | $740.00 |
| Oct 16, 2026 | J.P. Morgan | Idexx Laboratories price target lowered to $750 from $775 at JPMorgan | $750.00 |
| Aug 11, 2026 | Barclays | Idexx Laboratories price target lowered to $710 from $800 at Barclays | $710.00 |
| Jul 27, 2026 | UBS | Idexx Laboratories price target lowered to $620 from $640 at UBS | $620.00 |
| Apr 28, 2026 | UBS | Idexx Laboratories price target lowered to $640 from $730 at UBS | $640.00 |
| Feb 9, 2026 | Piper Sandler | Idexx Laboratories price target lowered to $750 from $775 at Piper Sandler | $750.00 |
| Feb 5, 2026 | Barclays | Idexx Laboratories price target lowered to $800 from $850 at Barclays | $800.00 |
| Feb 3, 2026 | BTIG | Idexx Laboratories price target lowered to $800 from $830 at BTIG | $800.00 |
| Feb 3, 2026 | UBS | Idexx Laboratories price target lowered to $730 from $750 at UBS | $730.00 |
| Dec 8, 2025 | Barclays | Idexx Laboratories initiated with an Overweight at Barclays | $850.00 |
| Nov 4, 2025 | BTIG | Idexx Laboratories price target raised to $830 from $785 at BTIG | $830.00 |
| Nov 4, 2025 | UBS | Idexx Laboratories price target raised to $750 from $710 at UBS | $750.00 |
| Nov 4, 2025 | Morgan Stanley | Idexx Laboratories price target raised to $805 from $765 at Morgan Stanley | $805.00 |